JumpStart invests in Milo Biotechnology
Clients JumpStart Inc.
Jones Day advised JumpStart Inc. in connection with its investment in Milo Biotechnology LLC, a company developing a therapy for muscular dystrophy patients.
Cases & Deals
Contacts
Practices
Locations
Before sending, please note:
Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.